RHE RSI Chart
Last 7 days
3.2%
Last 30 days
19.9%
Last 90 days
31.4%
Trailing 12 Months
-8.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 33.2M | 29.7M | 22.8M | 17.2M |
2022 | 26.3M | 27.9M | 32.2M | 35.9M |
2021 | 20.1M | 22.0M | 24.0M | 26.7M |
2020 | 19.3M | 18.5M | 18.4M | 17.6M |
2019 | 21.5M | 21.5M | 21.0M | 20.1M |
2018 | 25.0M | 24.0M | 22.9M | 22.0M |
2017 | 26.7M | 25.8M | 25.0M | 25.1M |
2016 | 23.9M | 26.6M | 27.7M | 27.6M |
2015 | 7.1M | 10.9M | 14.6M | 18.4M |
2014 | 179.0M | 144.2M | 95.6M | 3.3M |
2013 | 206.8M | 209.8M | 210.3M | 186.3M |
2012 | 154.0M | 171.4M | 184.1M | 198.9M |
2011 | 72.6M | 94.5M | 116.4M | 138.2M |
2010 | 0 | 0 | 0 | 50.8M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 30, 2023 | morrison brent | bought | 2,805 | 2.75 | 1,020 | ceo and president |
Aug 29, 2023 | morrison brent | bought | 100 | 2.71 | 37.00 | ceo and president |
Aug 28, 2023 | morrison brent | bought | 737 | 2.75 | 268 | ceo and president |
Aug 25, 2023 | morrison brent | bought | 2,519 | 2.66 | 947 | ceo and president |
Aug 25, 2023 | o'sullivan paul jason | bought | 2,690 | 2.69 | 1,000 | senior vice president |
Aug 24, 2023 | o'sullivan paul jason | bought | 7,025 | 2.81 | 2,500 | senior vice president |
Feb 16, 2022 | waites benjamin a | sold (taxes) | -12,772 | 4.51 | -2,832 | chief financial officer |
Feb 16, 2022 | morrison brent | sold (taxes) | -12,772 | 4.51 | -2,832 | ceo and president |
Jan 01, 2022 | morrison brent | acquired | - | - | 24,000 | ceo and president |
Aug 31, 2021 | tenwick david a | sold | -23,000 | 11.5 | -2,000 | - |
Which funds bought or sold RHE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 11.2 | 1,463 | 34,427 | -% |
Feb 14, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | sold off | -100 | -51,481 | - | -% |
Feb 14, 2024 | BARTLETT & CO. WEALTH MANAGEMENT LLC | unchanged | - | -10.00 | 286 | -% |
Feb 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | sold off | -100 | -28,000 | - | -% |
Feb 13, 2024 | BlackRock Inc. | sold off | -100 | -1,912 | - | -% |
Feb 13, 2024 | Tower Research Capital LLC (TRC) | reduced | -2.33 | -168 | 1,873 | -% |
Feb 13, 2024 | FMR LLC | new | - | 5.00 | 5.00 | -% |
Feb 13, 2024 | MORGAN STANLEY | sold off | -100 | -138 | - | -% |
Feb 09, 2024 | WELLS FARGO & COMPANY/MN | added | 0.1 | -131 | 2,059 | -% |
Feb 09, 2024 | CITIGROUP INC | unchanged | - | - | 2.00 | -% |
Unveiling Regional Health Properties Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Regional Health Properties Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 461.9B | 371.6B | 20.64 | 1.24 | ||||
CI | 103.1B | 195.3B | 19.18 | 0.53 | ||||
CVS | 87.8B | 357.8B | 10.51 | 0.25 | ||||
HCA | 80.7B | 65.0B | 15.4 | 1.24 | ||||
CNC | 40.2B | 154.0B | 14.86 | 0.26 | ||||
DVA | 11.2B | 12.1B | 16.21 | 0.92 | ||||
UHS | 10.9B | 14.3B | 15.2 | 0.76 | ||||
MID-CAP | ||||||||
CHE | 9.1B | 2.3B | 33.31 | 4.01 | ||||
ACHC | 6.5B | 2.9B | -298.84 | 2.21 | ||||
AMN | 2.2B | 3.8B | 10.24 | 0.57 | ||||
AMEH | 2.1B | 1.4B | 34.08 | 1.49 | ||||
SMALL-CAP | ||||||||
ADUS | 1.6B | 1.1B | 25.23 | 1.49 | ||||
BKD | 1.2B | 3.0B | -6.49 | 0.41 | ||||
BEAT | 50.8M | - | -3.47 | - | ||||
AMS | 18.9M | 21.3M | 35.51 | 0.89 |
Regional Health Properties Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 9.3% | 4,522 | 4,138 | 4,598 | 3,906 | 10,155 | 11,030 | 8,093 | 6,648 | 6,439 | 6,702 | 6,468 | 7,081 | 3,725 | 4,767 | 4,539 | 4,548 | 4,579 | 4,830 | 5,301 | 5,424 | 5,489 |
Operating Expenses | -4.0% | 4,363 | 4,542 | 4,412 | 4,651 | 13,129 | 13,001 | 8,622 | 7,987 | 6,107 | 6,096 | 5,982 | 5,966 | 4,024 | 4,137 | 3,458 | 3,666 | 3,380 | 3,538 | 3,684 | 4,070 | 4,863 |
S&GA Expenses | -19.1% | 787 | 972 | 1,011 | 1,206 | 1,225 | 1,378 | 921 | 1,123 | 960 | 980 | 952 | 1,036 | 1,039 | 743 | 714 | 877 | 641 | 730 | 895 | 926 | 941 |
EBITDA Margin | 30.9% | 0.23* | 0.17* | 0.13* | 0.11* | 0.11* | 0.12* | 0.14* | 0.15* | 0.15* | 0.16* | 0.18* | 0.24* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -3.3% | 685 | 708 | 679 | 680 | 674 | 564 | 639 | 653 | 647 | 669 | 666 | 687 | 686 | 692 | 684 | 715 | 730 | 1,157 | 1,724 | 1,654 | 1,334 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -44.00 | - | - | 44.00 | -71.00 |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | -713 | -17.00 | -441 | 34.00 | -962 | -71.00 | 406 | 23.00 | 489 | 5,710 | -1,375 | 50.00 | -2,029 |
EBT Margin | -32.8% | -0.07* | -0.05* | -0.04* | -0.03* | -0.03* | -0.04* | -0.04* | -0.04* | -0.04* | -0.06* | -0.07* | -0.03* | - | - | - | - | - | - | - | - | - |
Net Income | 100.0% | - | -973 | -685 | -1,992 | -2,244 | -371 | -1,325 | -2,927 | -661 | -39.00 | -503 | 21.00 | -1,013 | -73.00 | 412 | -14.00 | 748 | 5,811 | -1,243 | 184 | -1,642 |
Net Income Margin | -32.8% | -0.34* | -0.26* | -0.18* | -0.18* | -0.19* | -0.16* | -0.18* | -0.16* | -0.04* | -0.06* | -0.07* | -0.03* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -63.9% | 158 | 438 | -494 | 2,595 | -1,523 | 596 | -1,291 | -1,659 | 778 | 1,680 | -4.00 | 2,317 | 138 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -2.9% | 62.00 | 64.00 | 66.00 | 66.00 | 69.00 | 95.00 | 100 | 103 | 106 | 107 | 107 | 109 | 108 | 110 | 112 | 112 | 114 | 114 | 135 | 137 | 101 |
Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 | 26.00 | 5.00 | 8.00 |
Cash Equivalents | -9.7% | 4.00 | 5.00 | 5.00 | 6.00 | 4.00 | 5.00 | 6.00 | 8.00 | 10.00 | 10.00 | 9.00 | 9.00 | 7.00 | 8.00 | 7.00 | 7.00 | 8.00 | 7.00 | 5.00 | 5.00 | 6.00 |
Net PPE | -1.0% | 45.00 | 46.00 | 46.00 | 46.00 | 47.00 | 49.00 | 49.00 | 50.00 | 50.00 | 51.00 | 51.00 | 52.00 | 53.00 | 53.00 | 54.00 | 54.00 | 55.00 | 56.00 | 56.00 | 76.00 | 77.00 |
Goodwill | 0% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | -2.6% | 62.00 | 64.00 | 65.00 | 64.00 | 65.00 | 90.00 | 93.00 | 95.00 | 95.00 | 96.00 | 96.00 | 98.00 | 97.00 | 98.00 | 100 | 101 | 102 | 103 | 130 | 130 | 94.00 |
Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 40.00 | 39.00 | 37.00 |
Shareholder's Equity | -52.2% | 0.00 | 0.00 | 1.00 | 2.00 | 4.00 | 6.00 | 6.00 | 8.00 | 10.00 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 11.00 | 5.00 | 6.00 | 6.00 |
Retained Earnings | -0.3% | -81.90 | -81.66 | -80.69 | -123 | -121 | -119 | -118 | -117 | -114 | -113 | -113 | -113 | -113 | -112 | -112 | -112 | -112 | -113 | -119 | -117 | -118 |
Shares Outstanding | -2.3% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 0.00 | - | - | - | 21.00 | - | - | - | 3.00 | - | - | - | 3.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -60.0% | 200 | 500 | 403 | 2,597 | -1,425 | 627 | -1,219 | -1,579 | 782 | 1,725 | 37.00 | 2,350 | 379 | 1,000 | 51.00 | -135 | 1,211 | 750 | 600 | -165 | 1,291 |
Share Based Compensation | -57.6% | 36.00 | 85.00 | 155 | 81.00 | 60.00 | 58.00 | 4.00 | 111 | 179 | 179 | - | - | 12.00 | 13.00 | 12.00 | 12.00 | 22.00 | 22.00 | 21.00 | 27.00 | 50.00 |
Cashflow From Investing | 32.3% | -42.00 | -62.00 | -852 | -2.00 | -98.00 | -31.00 | -72.00 | -80.00 | -4.00 | -45.00 | -41.00 | -33.00 | -241 | -52.00 | - | -157 | 185 | 2,539 | -8.00 | 1,105 | -72.00 |
Cashflow From Financing | 1.8% | -661 | -673 | -460 | -685 | 35.00 | -723 | -701 | -673 | -556 | -653 | -584 | -622 | -392 | -379 | -184 | -436 | -448 | -1,054 | -1,010 | -2,153 | -356 |
Buy Backs | - | - | - | - | - | - | - | - | 46.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenues: | ||
Rental revenues | $ 7,069 | $ 12,794 |
Total revenues | 17,164 | 35,925 |
Expenses: | ||
Patient care expense | 9,200 | 20,453 |
Facility rent expense | 594 | 4,876 |
Cost of management fees | 595 | 619 |
Depreciation and amortization | 2,255 | 2,404 |
General and administrative expense | 3,976 | 4,652 |
Doubtful accounts expense | 1,150 | 4,916 |
Loss on disposal of assets | 1,417 | |
Loss on lease termination | 1,436 | |
Other operating expenses | 198 | 1,974 |
Total expenses | 17,968 | 42,747 |
Loss from operations | (804) | (6,822) |
Other (income) expense: | ||
Interest expense, net | 2,751 | 2,529 |
Loss on extinguishment of debt | 452 | |
Other (income) expense, net | 333 | (2,936) |
Total other (income) expense, net | 3,084 | 45 |
Net loss | (3,888) | (6,867) |
Preferred stock dividends - undeclared | (8,997) | |
Preferred stock dividends - gain on extinguishment | 43,395 | |
Net profit (loss) attributable to Regional Health Properties, Inc. common stockholders | $ 39,507 | $ (15,864) |
Net profit (loss) per share of common stock attributable to Regional Health Properties, Inc.: | ||
Net loss per share of common stock attributable to Regional Health Properties, Inc., basic | $ 21.05 | $ (8.93) |
Net loss per share of common stock attributable to Regional Health Properties, Inc., diluted | $ 21.05 | $ (8.93) |
Weighted average shares of common stock outstanding: | ||
Basic (in shares) | 1,877 | 1,776 |
Diluted (in shares) | 1,877 | 1,776 |
Patient Care Revenues | ||
Revenues: | ||
Patient care, management fees and other revenues | $ 8,835 | $ 22,060 |
Rental Revenue | ||
Revenues: | ||
Rental revenues | 7,069 | 12,794 |
Management Fees | ||
Revenues: | ||
Patient care, management fees and other revenues | 1,050 | 1,045 |
Other Revenues | ||
Revenues: | ||
Patient care, management fees and other revenues | $ 210 | $ 26 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
ASSETS | ||||
Property and equipment, net | $ 45,337 | $ 46,611 | ||
Cash | 953 | 843 | ||
Restricted cash | 3,231 | 3,066 | ||
Accounts receivable, net of allowances of $2,040 and $1,298 | 1,403 | 6,289 | ||
Prepaid expenses and other | 609 | 746 | ||
Notes receivable | 1,044 | 1,099 | ||
Intangible assets—bed licenses | 2,471 | 2,471 | ||
Intangible assets - lease rights, net | 87 | 110 | ||
Right-of-use operating lease assets | 2,556 | 2,848 | ||
Goodwill | [1] | 1,585 | 1,585 | |
Lease deposits and other deposits | 4 | |||
Straight-line rent receivable | 2,901 | 2,912 | ||
Total assets | 62,181 | 68,580 | ||
LIABILITIES AND EQUITY | ||||
Senior debt, net | 43,855 | 45,163 | ||
Bonds, net | 5,991 | 6,120 | ||
Other debt, net | 889 | 895 | ||
Accounts payable | 2,493 | 3,293 | ||
Accrued expenses | 4,060 | 5,036 | ||
Operating lease obligation | 2,917 | 3,226 | ||
Other liabilities | 1,791 | 1,131 | ||
Total liabilities | 61,996 | 64,864 | ||
Commitments and Contingencies (Note 15) | ||||
Stockholders' equity: | ||||
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,850 and 1,793 shares issued and 1,839 and 1,784 shares outstanding at December 31, 2023 and December 31, 2022, respectively | 63,059 | 62,702 | ||
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||||
Accumulated deficit | (81,902) | (121,409) | ||
Total stockholders' equity | 185 | 3,716 | ||
Total liabilities and stockholders' equity | 62,181 | 68,580 | ||
Series A Preferred Stock | ||||
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||||
Preferred stock | 426 | $ 62,423 | ||
Series B Preferred Stock | ||||
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||||
Preferred stock | $ 18,602 | |||
|